APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ketorolac Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchKetorolac Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ketorolac Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ketorolac Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ketorolac Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ketorolac Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ketorolac Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ketorolac Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ketorolac Injection Segment by Company

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Ketorolac Injection Segment by Concentration

15mg/ml

30mg/ml

Ketorolac Injection Segment by Application

Hospital

Clinics

Others

Ketorolac Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ketorolac Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ketorolac Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ketorolac Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ketorolac Injection Industry Trends Table 2. Ketorolac Injection Industry Drivers Table 3. Ketorolac Injection Industry Opportunities and Challenges Table 4. Ketorolac Injection Industry Restraints Table 5. Global Ketorolac Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ketorolac Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ketorolac Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Ketorolac Injection Sales Market Share by Manufacturers Table 9. Global Ketorolac Injection Average Sales Price (US$/K Units) of Manufacturers (2021-2026) Table 10. Global Ketorolac Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ketorolac Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ketorolac Injection Manufacturers, Product Type & Application Table 13. Global Ketorolac Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ketorolac Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 15mg/ml Table 17. Major Manufacturers of 30mg/ml Table 18. Global Ketorolac Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Ketorolac Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Ketorolac Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Ketorolac Injection Sales Market Share by Type (2021-2026) Table 22. Global Ketorolac Injection Sales Market Share by Type (2027-2032) Table 23. Global Ketorolac Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Ketorolac Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Ketorolac Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Ketorolac Injection Revenue Market Share by Type (2021-2026) Table 27. Global Ketorolac Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Ketorolac Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Ketorolac Injection Sales Market Share by Application (2021-2026) Table 35. Global Ketorolac Injection Sales Market Share by Application (2027-2032) Table 36. Global Ketorolac Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Ketorolac Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Ketorolac Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Ketorolac Injection Revenue Market Share by Application (2021-2026) Table 40. Global Ketorolac Injection Revenue Market Share by Application (2027-2032) Table 41. Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Ketorolac Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Ketorolac Injection Sales Market Share by Region (2021-2026) Table 44. Global Ketorolac Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Ketorolac Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Ketorolac Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ketorolac Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Ketorolac Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Ketorolac Injection Revenue Market Share by Region (2021-2026) Table 62. Global Ketorolac Injection Revenue Market Share by Region (2027-2032) Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pfizer Ketorolac Injection Product Portfolio Table 67. Pfizer Recent Development Table 68. Fresenius Kabi Company Information Table 69. Fresenius Kabi Business Overview Table 70. Fresenius Kabi Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Fresenius Kabi Ketorolac Injection Product Portfolio Table 72. Fresenius Kabi Recent Development Table 73. Fosun Pharma (Gland Pharma) Company Information Table 74. Fosun Pharma (Gland Pharma) Business Overview Table 75. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio Table 77. Fosun Pharma (Gland Pharma) Recent Development Table 78. Sagent Pharmaceuticals Company Information Table 79. Sagent Pharmaceuticals Business Overview Table 80. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio Table 82. Sagent Pharmaceuticals Recent Development Table 83. Hikma Company Information Table 84. Hikma Business Overview Table 85. Hikma Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hikma Ketorolac Injection Product Portfolio Table 87. Hikma Recent Development Table 88. Lunan Pharma Company Information Table 89. Lunan Pharma Business Overview Table 90. Lunan Pharma Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lunan Pharma Ketorolac Injection Product Portfolio Table 92. Lunan Pharma Recent Development Table 93. Alvogen Company Information Table 94. Alvogen Business Overview Table 95. Alvogen Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Alvogen Ketorolac Injection Product Portfolio Table 97. Alvogen Recent Development Table 98. Chengdu Brilliant Pharmaceuticals Company Information Table 99. Chengdu Brilliant Pharmaceuticals Business Overview Table 100. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio Table 102. Chengdu Brilliant Pharmaceuticals Recent Development Table 103. Athenex Company Information Table 104. Athenex Business Overview Table 105. Athenex Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Athenex Ketorolac Injection Product Portfolio Table 107. Athenex Recent Development Table 108. Sichuan Medcalo Company Information Table 109. Sichuan Medcalo Business Overview Table 110. Sichuan Medcalo Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sichuan Medcalo Ketorolac Injection Product Portfolio Table 112. Sichuan Medcalo Recent Development Table 113. Julphar Bangladesh Ltd. Company Information Table 114. Julphar Bangladesh Ltd. Business Overview Table 115. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio Table 117. Julphar Bangladesh Ltd. Recent Development Table 118. Yung Shin Pharm Company Information Table 119. Yung Shin Pharm Business Overview Table 120. Yung Shin Pharm Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Yung Shin Pharm Ketorolac Injection Product Portfolio Table 122. Yung Shin Pharm Recent Development Table 123. Tianjin Chase Sun Pharmaceutical Company Information Table 124. Tianjin Chase Sun Pharmaceutical Business Overview Table 125. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio Table 127. Tianjin Chase Sun Pharmaceutical Recent Development Table 128. ZISKA Pharmaceuticals Company Information Table 129. ZISKA Pharmaceuticals Business Overview Table 130. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Price (US$/K Units), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio Table 132. ZISKA Pharmaceuticals Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Ketorolac Injection Distributors List Table 136. Ketorolac Injection Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Ketorolac Injection Product Image Figure 2. Global Ketorolac Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Injection Sales (2021-2032) & (K Units) Figure 5. Global Ketorolac Injection Average Price (US$/K Units) & (2021-2032) Figure 6. Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 15mg/ml Image Figure 9. 30mg/ml Image Figure 10. Global Ketorolac Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Ketorolac Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Ketorolac Injection Sales Market Share by Type (2021-2032) Figure 13. Global Ketorolac Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Ketorolac Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ketorolac Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Ketorolac Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Ketorolac Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Ketorolac Injection Sales Market Share by Application (2021-2032) Figure 22. Global Ketorolac Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Ketorolac Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ketorolac Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Ketorolac Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Ketorolac Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Ketorolac Injection Sales Market Share by Country (2021-2032) Figure 39. China Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Ketorolac Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Ketorolac Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Ketorolac Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Ketorolac Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Ketorolac Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ketorolac Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ketorolac Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Ketorolac Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ketorolac Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Ketorolac Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 30mg/ml
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Fosun Pharma (Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharma
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ketorolac Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ketorolac Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ketorolac Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ketorolac Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ketorolac Injection Market Dynamics
  1. 2.1 Ketorolac Injection Industry Trends
  2. 2.2 Ketorolac Injection Industry Drivers
  3. 2.3 Ketorolac Injection Industry Opportunities and Challenges
  4. 2.4 Ketorolac Injection Industry Restraints
3 Ketorolac Injection Market by Manufacturers
  1. 3.1 Global Ketorolac Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ketorolac Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ketorolac Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ketorolac Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ketorolac Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ketorolac Injection Manufacturers, Product Type & Application
  7. 3.7 Global Ketorolac Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ketorolac Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ketorolac Injection Tier 1, Tier 2, and Tier 3
4 Ketorolac Injection Market by Type
  1. 4.1 Ketorolac Injection Type Introduction
  2. 4.1.1 15mg/ml
  3. 4.1.2 30mg/ml
  4. 4.2 Global Ketorolac Injection Sales by Type
  5. 4.2.1 Global Ketorolac Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ketorolac Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Ketorolac Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Ketorolac Injection Revenue by Type
  9. 4.3.1 Global Ketorolac Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ketorolac Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Ketorolac Injection Revenue Market Share by Type (2021-2032)
5 Ketorolac Injection Market by Application
  1. 5.1 Ketorolac Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Injection Sales by Application
  6. 5.2.1 Global Ketorolac Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Ketorolac Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ketorolac Injection Revenue by Application
  10. 5.3.1 Global Ketorolac Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ketorolac Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Ketorolac Injection Revenue Market Share by Application (2021-2032)
6 Global Ketorolac Injection Sales by Region
  1. 6.1 Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ketorolac Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ketorolac Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Ketorolac Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ketorolac Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ketorolac Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ketorolac Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ketorolac Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ketorolac Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ketorolac Injection Revenue by Region
  1. 7.1 Global Ketorolac Injection Revenue by Region
  2. 7.1.1 Global Ketorolac Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ketorolac Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Ketorolac Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Ketorolac Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ketorolac Injection Revenue (2021-2032)
  8. 7.2.2 North America Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ketorolac Injection Revenue (2021-2032)
  11. 7.3.2 Europe Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ketorolac Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ketorolac Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ketorolac Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Ketorolac Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 Fosun Pharma (Gland Pharma)
  14. 8.3.1 Fosun Pharma (Gland Pharma) Company Information
  15. 8.3.2 Fosun Pharma (Gland Pharma) Business Overview
  16. 8.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
  18. 8.3.5 Fosun Pharma (Gland Pharma) Recent Developments
  19. 8.4 Sagent Pharmaceuticals
  20. 8.4.1 Sagent Pharmaceuticals Company Information
  21. 8.4.2 Sagent Pharmaceuticals Business Overview
  22. 8.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
  24. 8.4.5 Sagent Pharmaceuticals Recent Developments
  25. 8.5 Hikma
  26. 8.5.1 Hikma Company Information
  27. 8.5.2 Hikma Business Overview
  28. 8.5.3 Hikma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hikma Ketorolac Injection Product Portfolio
  30. 8.5.5 Hikma Recent Developments
  31. 8.6 Lunan Pharma
  32. 8.6.1 Lunan Pharma Company Information
  33. 8.6.2 Lunan Pharma Business Overview
  34. 8.6.3 Lunan Pharma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
  36. 8.6.5 Lunan Pharma Recent Developments
  37. 8.7 Alvogen
  38. 8.7.1 Alvogen Company Information
  39. 8.7.2 Alvogen Business Overview
  40. 8.7.3 Alvogen Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alvogen Ketorolac Injection Product Portfolio
  42. 8.7.5 Alvogen Recent Developments
  43. 8.8 Chengdu Brilliant Pharmaceuticals
  44. 8.8.1 Chengdu Brilliant Pharmaceuticals Company Information
  45. 8.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
  46. 8.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
  48. 8.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  49. 8.9 Athenex
  50. 8.9.1 Athenex Company Information
  51. 8.9.2 Athenex Business Overview
  52. 8.9.3 Athenex Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Athenex Ketorolac Injection Product Portfolio
  54. 8.9.5 Athenex Recent Developments
  55. 8.10 Sichuan Medcalo
  56. 8.10.1 Sichuan Medcalo Company Information
  57. 8.10.2 Sichuan Medcalo Business Overview
  58. 8.10.3 Sichuan Medcalo Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
  60. 8.10.5 Sichuan Medcalo Recent Developments
  61. 8.11 Julphar Bangladesh Ltd.
  62. 8.11.1 Julphar Bangladesh Ltd. Company Information
  63. 8.11.2 Julphar Bangladesh Ltd. Business Overview
  64. 8.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
  66. 8.11.5 Julphar Bangladesh Ltd. Recent Developments
  67. 8.12 Yung Shin Pharm
  68. 8.12.1 Yung Shin Pharm Company Information
  69. 8.12.2 Yung Shin Pharm Business Overview
  70. 8.12.3 Yung Shin Pharm Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
  72. 8.12.5 Yung Shin Pharm Recent Developments
  73. 8.13 Tianjin Chase Sun Pharmaceutical
  74. 8.13.1 Tianjin Chase Sun Pharmaceutical Company Information
  75. 8.13.2 Tianjin Chase Sun Pharmaceutical Business Overview
  76. 8.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
  78. 8.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
  79. 8.14 ZISKA Pharmaceuticals
  80. 8.14.1 ZISKA Pharmaceuticals Company Information
  81. 8.14.2 ZISKA Pharmaceuticals Business Overview
  82. 8.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
  84. 8.14.5 ZISKA Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ketorolac Injection Value Chain Analysis
  2. 9.1.1 Ketorolac Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ketorolac Injection Production Mode & Process
  6. 9.2 Ketorolac Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ketorolac Injection Distributors
  9. 9.2.3 Ketorolac Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst